540 related articles for article (PubMed ID: 17449019)
1. Investigation on the early events of apoptosis in senescent erythrocytes with special emphasis on intracellular free calcium and loss of phospholipid asymmetry in chronic renal failure.
Sakthivel R; Farooq SM; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2007 Jul; 382(1-2):1-7. PubMed ID: 17449019
[TBL] [Abstract][Full Text] [Related]
2. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
Bi SH; Cheng LT; Wang T
Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
[TBL] [Abstract][Full Text] [Related]
3. Loss of phospholipid membrane asymmetry and sialylated glycoconjugates from erythrocyte surface in haemoglobin E beta-thalassaemia.
Basu S; Banerjee D; Chandra S; Chakrabarti A
Br J Haematol; 2008 Apr; 141(1):92-9. PubMed ID: 18324971
[TBL] [Abstract][Full Text] [Related]
4. Increased erythrocyte phosphatidylserine exposure in chronic renal failure.
Bonomini M; Sirolli V; Settefrati N; Dottori S; Di Liberato L; Arduini A
J Am Soc Nephrol; 1999 Sep; 10(9):1982-90. PubMed ID: 10477151
[TBL] [Abstract][Full Text] [Related]
5. [Calpain-calpastatin system in erythrocytes of children with chronic renal failure].
Polak-Jonkisz D; Purzyc L; Zwolińska D; Musiał K
Przegl Lek; 2006; 63 Suppl 3():156-8. PubMed ID: 16898518
[TBL] [Abstract][Full Text] [Related]
6. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
[TBL] [Abstract][Full Text] [Related]
7. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling.
Wann JG; Lin CS; Chang LC; Hsu YH; Chien CT; Tai DW; Chen JS; Yang CC; Yeung LK; Chen CF
Am J Kidney Dis; 2006 Jun; 47(6):1055-63. PubMed ID: 16731301
[TBL] [Abstract][Full Text] [Related]
12. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine.
Bonomini M; Sirolli V; Merciaro G; Antidormi T; Di Liberato L; Brummer U; Papponetti M; Cappelli P; Di Gregorio P; Arduini A
Nephrol Dial Transplant; 2005 Feb; 20(2):361-6. PubMed ID: 15598665
[TBL] [Abstract][Full Text] [Related]
13. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
14. The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients.
Cohen G; Raupachova J; Wimmer T; Deicher R; Hörl WH
Nephrol Dial Transplant; 2008 Aug; 23(8):2512-9. PubMed ID: 18319358
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte membrane phosphatidylserine exposure in obesity.
Solá E; Vayá A; Martínez M; Moscardó A; Corella D; Santaolaria ML; España F; Hernández-Mijares A
Obesity (Silver Spring); 2009 Feb; 17(2):318-22. PubMed ID: 19023282
[TBL] [Abstract][Full Text] [Related]
16. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells.
Pandolfi A; Di Pietro N; Sirolli V; Giardinelli A; Di Silvestre S; Amoroso L; Di Tomo P; Capani F; Consoli A; Bonomini M
J Cell Physiol; 2007 Dec; 213(3):699-709. PubMed ID: 17516566
[TBL] [Abstract][Full Text] [Related]
18. [Erythrone system in aged patients with chronic cardiac insufficiency].
Romashchenko OV; Kamenev VF; Tret'iakov AIu; Alferov PK
Klin Med (Mosk); 2009; 87(8):21-5. PubMed ID: 19827525
[TBL] [Abstract][Full Text] [Related]
19. Platelet membrane fluidity and intraplatelet Ca2+ homeostasis are affected in uremia.
Walkowiak B; Koziołkiewicz W; Michalec L; Borkowska E; Cierniewski CS
Pol J Pharmacol; 1996; 48(3):299-302. PubMed ID: 9112666
[TBL] [Abstract][Full Text] [Related]
20. Copper, zinc, calcium and magnesium in chronic renal failure.
Avasthi G; Singh HP; Katyal JC; Avasthi R; Aggarwal SP
J Assoc Physicians India; 1991 Jul; 39(7):531-4. PubMed ID: 1800497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]